Global and Japan Naloxone Market 2020 by Manufacturers, Type and Application, Forecast to 2025
Market Overview
The global Naloxone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 30790 million by 2025, from USD 27550 million in 2019.
The Naloxone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Naloxone market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Naloxone market has been segmented into Spray forms, Injectable forms, etc.
Breakdown by Application, Naloxone has been segmented into Opioid overdose, Preventing opioid abuse, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Naloxone market presented in the report. This section sheds light on the sales growth of different regional and country-level Naloxone markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Naloxone market.
For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Naloxone Market Share Analysis
Naloxone competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Naloxone sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Naloxone sales, revenue and market share for each player covered in this report.
The major players covered in Naloxone are: ADAPT Pharma, Mylan, kaleo, Amphastar Pharmaceuticals, West Ward Pharmaceuticals, Pfizer, Amneal Pharmaceuticals, Sandoz, etc. Among other players domestic and global, Naloxone market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Naloxone market are listed below:
ADAPT Pharma
Mylan
kaleo
Amphastar Pharmaceuticals
West Ward Pharmaceuticals
Pfizer
Amneal Pharmaceuticals
Sandoz
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Spray forms
Injectable forms
Market segment by Application, can be divided into
Opioid overdose
Preventing opioid abuse
Table of Contents
1 Market Overview
1.1 Naloxone Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Naloxone Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Spray forms
1.2.3 Injectable forms
1.3 Market Analysis by Application
1.3.1 Overview: Global Naloxone Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Opioid overdose
1.3.3 Preventing opioid abuse
1.4 Global Naloxone Market Size and Forecast (2015-2025)
1.4.1 Global Naloxone Revenue and Forecast (2015-2025)
1.4.2 Global Naloxone Sales and Forecast (2015-2025)
1.5 Global Naloxone Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 ADAPT Pharma
2.1.1 ADAPT Pharma Details
2.1.2 ADAPT Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 ADAPT Pharma SWOT Analysis
2.1.4 ADAPT Pharma Product and Services
2.1.5 ADAPT Pharma Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 kaleo
2.3.1 kaleo Details
2.3.2 kaleo Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 kaleo SWOT Analysis
2.3.4 kaleo Product and Services
2.3.5 kaleo Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amphastar Pharmaceuticals
2.4.1 Amphastar Pharmaceuticals Details
2.4.2 Amphastar Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amphastar Pharmaceuticals SWOT Analysis
2.4.4 Amphastar Pharmaceuticals Product and Services
2.4.5 Amphastar Pharmaceuticals Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 West Ward Pharmaceuticals
2.5.1 West Ward Pharmaceuticals Details
2.5.2 West Ward Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 West Ward Pharmaceuticals SWOT Analysis
2.5.4 West Ward Pharmaceuticals Product and Services
2.5.5 West Ward Pharmaceuticals Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amneal Pharmaceuticals
2.7.1 Amneal Pharmaceuticals Details
2.7.2 Amneal Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amneal Pharmaceuticals SWOT Analysis
2.7.4 Amneal Pharmaceuticals Product and Services
2.7.5 Amneal Pharmaceuticals Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Sandoz
2.8.1 Sandoz Details
2.8.2 Sandoz Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Sandoz SWOT Analysis
2.8.4 Sandoz Product and Services
2.8.5 Sandoz Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Naloxone Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Naloxone Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Naloxone Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: Japan
3.2.1 Key Players Naloxone Sales in Japan (2018-2019)
3.2.2 Japan Naloxone Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Naloxone Manufacturer Market Share in 2019
3.3.2 Top 6 Naloxone Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Naloxone Market Size by Geography (2015-2020)
4.1.1 Global Naloxone Sales by Geography (2015-2020)
4.1.2 Global Naloxone Revenue by Regions (2015-2020)
4.2 Global Naloxone Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Naloxone Sales and Forecast by Regions (2020-2025)
4.2.2 Global Naloxone Revenue and Forecast by Regions (2020-2025)
4.3 North America Naloxone Market Size and Forecast (2015-2025)
4.4 Europe Naloxone Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Naloxone Market Size and Forecast (2015-2025)
4.6 South America Naloxone Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Naloxone Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Naloxone Market Size by Country (2015-2020)
5.1.1 North America Naloxone Sales and Market Share by Country (2015-2020)
5.1.2 North America Naloxone Revenue and Market Share by Country (2015-2020)
5.2 North America Naloxone Market Size and Forecast by Country (2020-2025)
5.2.1 North America Naloxone Sales and Forecast by Country (2020-2025)
5.2.2 North America Naloxone Revenue and Forecast by Country (2020-2025)
5.3 United States Naloxone Market Size and Forecast (2015-2025)
5.4 Canada Naloxone Market Size and Forecast (2015-2025)
5.5 Mexico Naloxone Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Naloxone Market Size by Country (2015-2020)
6.1.1 Europe Naloxone Sales by Country (2015-2020)
6.1.2 Europe Naloxone Revenue by Country (2015-2020)
6.2 Europe Naloxone Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Naloxone Sales and Forecast by Country (2020-2025)
6.2.2 Europe Naloxone Revenue and Forecast by Country (2020-2025)
6.3 Germany Naloxone Market Size and Forecast (2015-2025)
6.4 United Kingdom Naloxone Market Size and Forecast (2015-2025)
6.5 France Naloxone Market Size and Forecast (2015-2025)
6.6 Russia Naloxone Market Size and Forecast (2015-2025)
6.7 Italy Naloxone Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Naloxone Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Naloxone Sales by Region (2015-2020)
7.1.2 Asia-Pacific Naloxone Revenue by Region (2015-2020)
7.2 Asia-Pacific Naloxone Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Naloxone Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Naloxone Revenue and Forecast by Region (2020-2025)
7.3 China Naloxone Market Size and Forecast (2015-2025)
7.4 Japan Naloxone Market Size and Forecast (2015-2025)
7.5 Korea Naloxone Market Size and Forecast (2015-2025)
7.6 India Naloxone Market Size and Forecast (2015-2025)
7.7 Southeast Asia Naloxone Market Size and Forecast (2015-2025)
7.8 Australia Naloxone Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Naloxone Market Size by Country (2015-2020)
8.1.1 South America Naloxone Sales by Country (2015-2020)
8.1.2 South America Naloxone Revenue by Country (2015-2020)
8.2 South America Naloxone Market Size and Forecast by Country (2020-2025)
8.2.1 South America Naloxone Sales and Forecast by Country (2020-2025)
8.2.2 South America Naloxone Revenue and Forecast by Country (2020-2025)
8.3 Brazil Naloxone Market Size and Forecast (2015-2025)
8.4 Argentina Naloxone Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Naloxone Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Naloxone Sales by Country (2015-2020)
9.1.2 Middle East & Africa Naloxone Revenue by Country (2015-2020)
9.2 Middle East & Africa Naloxone Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Naloxone Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Naloxone Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Naloxone Market Size and Forecast (2015-2025)
9.4 Turkey Naloxone Market Size and Forecast (2015-2025)
9.5 Egypt Naloxone Market Size and Forecast (2015-2025)
9.6 South Africa Naloxone Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Naloxone Market Size by Type (2015-2020)
10.1.1 Global Naloxone Sales by Type (2015-2020)
10.1.2 Global Naloxone Revenue by Type (2015-2020)
10.1.3 Global Naloxone Price by Type (2015-2020)
10.2 Global Naloxone Market Size and Forecast by Type (2020-2025)
10.2.1 Global Naloxone Sales and Forecast by Type (2020-2025)
10.2.2 Global Naloxone Revenue and Forecast by Type (2020-2025)
10.2.3 Global Naloxone Price and Forecast by Type (2020-2025)
10.3 Japan Naloxone Market Size and Forecast by Type (2015-2025)
10.3.1 Japan Naloxone Market Size by Type (2015-2020)
10.3.2 Japan Naloxone Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Naloxone Market Size by Application (2015-2020)
11.1.1 Global Naloxone Sales by Application (2015-2020)
11.1.2 Global Naloxone Revenue by Application (2015-2020)
11.1.3 Global Naloxone Price by Application (2015-2020)
11.2 Global Naloxone Market Size and Forecast by Application (2020-2025)
11.2.1 Global Naloxone Sales and Forecast by Application (2020-2025)
11.2.2 Global Naloxone Revenue and Forecast by Application (2020-2025)
11.2.3 Global Naloxone Price and Forecast by Application (2020-2025)
11.3 Japan Naloxone Market Size and Forecast by Application (2015-2025)
11.3.1 Japan Naloxone Market Size by Application (2015-2020)
11.3.2 Japan Naloxone Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Naloxone Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Naloxone by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Naloxone Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Naloxone Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. ADAPT Pharma Basic Information, Manufacturing Base and Competitors
Table 6. ADAPT Pharma Naloxone Major Business
Table 7. ADAPT Pharma Naloxone Total Revenue (USD Million) (2018-2019)
Table 8. ADAPT Pharma SWOT Analysis
Table 9. ADAPT Pharma Naloxone Product and Services
Table 10. ADAPT Pharma Naloxone Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Naloxone Major Business
Table 13. Mylan Naloxone Total Revenue (USD Million) (2018-2019)
Table 14. Mylan SWOT Analysis
Table 15. Mylan Naloxone Product and Services
Table 16. Mylan Naloxone Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. kaleo Basic Information, Manufacturing Base and Competitors
Table 18. kaleo Naloxone Major Business
Table 19. kaleo Naloxone Total Revenue (USD Million) (2018-2019)
Table 20. kaleo SWOT Analysis
Table 21. kaleo Naloxone Product and Services
Table 22. kaleo Naloxone Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Amphastar Pharmaceuticals Naloxone Major Business
Table 25. Amphastar Pharmaceuticals Naloxone Total Revenue (USD Million) (2018-2019)
Table 26. Amphastar Pharmaceuticals SWOT Analysis
Table 27. Amphastar Pharmaceuticals Naloxone Product and Services
Table 28. Amphastar Pharmaceuticals Naloxone Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. West Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 30. West Ward Pharmaceuticals Naloxone Major Business
Table 31. West Ward Pharmaceuticals Naloxone Total Revenue (USD Million) (2018-2019)
Table 32. West Ward Pharmaceuticals SWOT Analysis
Table 33. West Ward Pharmaceuticals Naloxone Product and Services
Table 34. West Ward Pharmaceuticals Naloxone Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Pfizer Basic Information, Manufacturing Base and Competitors
Table 36. Pfizer Naloxone Major Business
Table 37. Pfizer Naloxone Total Revenue (USD Million) (2018-2019)
Table 38. Pfizer SWOT Analysis
Table 39. Pfizer Naloxone Product and Services
Table 40. Pfizer Naloxone Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 42. Amneal Pharmaceuticals Naloxone Major Business
Table 43. Amneal Pharmaceuticals Naloxone Total Revenue (USD Million) (2018-2019)
Table 44. Amneal Pharmaceuticals SWOT Analysis
Table 45. Amneal Pharmaceuticals Naloxone Product and Services
Table 46. Amneal Pharmaceuticals Naloxone Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Sandoz Basic Information, Manufacturing Base and Competitors
Table 48. Sandoz Naloxone Major Business
Table 49. Sandoz Naloxone Total Revenue (USD Million) (2018-2019)
Table 50. Sandoz SWOT Analysis
Table 51. Sandoz Naloxone Product and Services
Table 52. Sandoz Naloxone Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Global Naloxone Sales by Manufacturer (2018-2019) (K Units)
Table 54. Global Naloxone Revenue by Manufacturer (2018-2019) (USD Million)
Table 55. Key Players Naloxone Sales in Japan (2018-2019) (K Units)
Table 56. Key Players Naloxone Sales Market Share in Japan (2018-2019)
Table 57. Key Players Revenue of Naloxone in Japan (2018-2019) (USD Million)
Table 58. Global Naloxone Sales by Regions (2015-2020) (K Units)
Table 59. Global Naloxone Sales Market Share by Regions (2015-2020)
Table 60. Global Naloxone Revenue by Regions (2015-2020) (USD Million)
Table 61. Global Naloxone Sales and Forecast by Regions (2020-2025) (K Units)
Table 62. Global Naloxone Sales Market Share by Regions (2020-2025)
Table 63. Global Naloxone Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 64. Global Naloxone Revenue Market Share by Regions (2020-2025) (USD Million)
Table 65. North America Naloxone Sales by Countries (2015-2020) (K Units)
Table 66. North America Naloxone Sales Market Share by Countries (2015-2020)
Table 67. North America Naloxone Revenue by Countries (2015-2020) (USD Million)
Table 68. North America Naloxone Revenue Market Share by Countries (2015-2020)
Table 69. North America Naloxone Sales by Country (2020-2025) (K Units)
Table 70. North America Naloxone Sales Market Share by Country (2020-2025)
Table 71. North America Naloxone Revenue by Country (2020-2025) (USD Million)
Table 72. North America Naloxone Revenue Market Share by Country (2020-2025)
Table 73. Europe Naloxone Sales by Countries (2015-2020) (K Units)
Table 74. Europe Naloxone Sales Market Share by Countries (2015-2020)
Table 75. Europe Naloxone Revenue by Countries (2015-2020) (USD Million)
Table 76. Europe Naloxone Revenue Market Share by Countries (2015-2020)
Table 77. Europe Naloxone Sales by Country (2020-2025) (K Units)
Table 78. Europe Naloxone Sales Market Share by Country (2020-2025)
Table 79. Europe Naloxone Revenue by Country (2020-2025) (USD Million)
Table 80. Europe Naloxone Revenue Market Share by Country (2020-2025)
Table 81. Asia-Pacific Naloxone Sales by Countries (2015-2020) (K Units)
Table 82. Asia-Pacific Naloxone Sales Market Share by Countries (2015-2020)
Table 83. Asia-Pacific Naloxone Revenue by Countries (2015-2020) (USD Million)
Table 84. Asia-Pacific Naloxone Revenue Market Share by Countries (2015-2020)
Table 85. Asia-Pacific Naloxone Sales by Country (2020-2025) (K Units)
Table 86. Asia-Pacific Naloxone Sales Market Share by Country (2020-2025)
Table 87. Asia-Pacific Naloxone Revenue by Country (2020-2025) (USD Million)
Table 88. Asia-Pacific Naloxone Revenue Market Share by Country (2020-2025)
Table 89. South America Naloxone Sales by Countries (2015-2020) (K Units)
Table 90. South America Naloxone Sales Market Share by Countries (2015-2020)
Table 91. South America Naloxone Revenue by Countries (2015-2020) (USD Million)
Table 92. South America Naloxone Revenue Market Share by Countries (2015-2020)
Table 93. South America Naloxone Sales by Country (2020-2025) (K Units)
Table 94. South America Naloxone Sales Market Share by Country (2020-2025)
Table 95. South America Naloxone Revenue by Country (2020-2025) (USD Million)
Table 96. South America Naloxone Revenue Market Share by Country (2020-2025)
Table 97. Middle East & Africa Naloxone Sales by Countries (2015-2020) (K Units)
Table 98. Middle East & Africa Naloxone Sales Market Share by Countries (2015-2020)
Table 99. Middle East & Africa Naloxone Revenue by Countries (2015-2020) (USD Million)
Table 100. Middle East & Africa Naloxone Revenue Market Share by Countries (2015-2020)
Table 101. Middle East & Africa Naloxone Sales by Country (2020-2025) (K Units)
Table 102. Middle East & Africa Naloxone Sales Market Share by Country (2020-2025)
Table 103. Middle East & Africa Naloxone Revenue by Country (2020-2025) (USD Million)
Table 104. Middle East & Africa Naloxone Revenue Market Share by Country (2020-2025)
Table 105. Japan Naloxone Sales by Type (2015-2020) (K Units)
Table 106. Japan Naloxone Sales Market Share by Type (2015-2020)
Table 107. Japan Naloxone Revenue by Type (2015-2020) (USD Million)
Table 108. Japan Naloxone Revenue Market Share by Type (2015-2020)
Table 109. Japan Naloxone Sales by Type (2020-2025) (K Units)
Table 110. Japan Naloxone Sales Market Share by Type (2020-2025)
Table 111. Japan Naloxone Revenue by Type (2020-2025) (USD Million)
Table 112. Japan Naloxone Revenue Market Share by Type (2020-2025)
Table 113. Global Naloxone Sales by Application (2015-2020) (K Units)
Table 114. Global Naloxone Sales Market Share by Application (2015-2020)
Table 115. Global Naloxone Revenue by Application (2015-2020) (USD Million)
Table 116. Global Naloxone Revenue Market Share by Application (2015-2020)
Table 117. Global Naloxone Price by Application (2015-2020) (USD/Unit)
Table 118. Global Naloxone Sales by Application (2020-2025) (K Units)
Table 119. Global Naloxone Sales Market Share by Application (2020-2025)
Table 120. Global Naloxone Revenue by Application (2020-2025) (USD Million)
Table 121. Global Naloxone Revenue Market Share by Application (2020-2025)
Table 122. Global Naloxone Price by Application (2020-2025) (USD/Unit)
Table 123. Japan Naloxone Sales by Application (2015-2020) (K Units)
Table 124. Japan Naloxone Sales Market Share by Application (2015-2020)
Table 125. Japan Naloxone Revenue by Application (2015-2020) (USD Million)
Table 126. Japan Naloxone Revenue Market Share by Application (2015-2020)
Table 127. Japan Naloxone Sales by Application (2020-2025) (K Units)
Table 128. Japan Naloxone Sales Market Share by Application (2020-2025)
Table 129. Japan Naloxone Revenue by Application (2020-2025) (USD Million)
Table 130. Japan Naloxone Revenue Market Share by Application (2020-2025)
Table 131. Direct Channel Pros & Cons
Table 132. Indirect Channel Pros & Cons
Table 133. Distributors/Traders/ Dealers List
Table 134. Customers of Naloxone
Table 135. Market Opportunities in Next Few Years
Table 136. Market Risks Analysis
Table 137. Market Drivers
List of Figures
Figure 1. Naloxone Picture
Figure 2. Global Naloxone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Spray forms Picture
Figure 4. Injectable forms Picture
Figure 5. Naloxone Sales Market Share by Application in 2019
Figure 6. Opioid overdose Picture
Figure 7. Preventing opioid abuse Picture
Figure 8. Global Naloxone Market Status and Outlook (2015-2025) (USD Million)
Figure 9. Global Naloxone Sales Growth Rate (2015-2025) (K Units)
Figure 10. Global Naloxone Sales Market Share by Manufacturer in 2019
Figure 11. Global Naloxone Revenue Market Share by Manufacturer in 2019
Figure 12. Key Players Naloxone Revenue Market Share in Japan in 2019
Figure 13. Global Top 5 Naloxone Manufacturer Market Share in 2019
Figure 14. Top 3 Naloxone Players Market Share in Japan in 2019
Figure 15. Global Naloxone Revenue Market Share by Regions in 2019
Figure 16. North America Naloxone Sales YoY Growth (2015-2025) (K Units)
Figure 17. North America Naloxone Revenue YoY Growth (2015-2025) (USD Million)
Figure 18. Europe Naloxone Sales YoY Growth (2015-2020) (K Units)
Figure 19. Europe Naloxone Revenue YoY Growth (2015-2020) (USD Million)
Figure 20. Asia-Pacific Naloxone Sales YoY Growth (2015-2020) (K Units)
Figure 21. Asia-Pacific Naloxone Revenue YoY Growth (2015-2020) (USD Million)
Figure 22. South America Naloxone Sales YoY Growth (2015-2020) (K Units)
Figure 23. South America Naloxone Revenue YoY Growth (2015-2020) (USD Million)
Figure 24. Middle East & Africa Naloxone Sales YoY Growth (2015-2020) (K Units)
Figure 25. Middle East & Africa Naloxone Revenue YoY Growth (2015-2020) (USD Million)
Figure 26. North America Naloxone Sales Market Share by Country in 2019
Figure 27. North America Naloxone Revenue Market Share by Country in 2019
Figure 28. United States Naloxone Market Size and Growth Rate (2015-2025) (USD Million)
Figure 29. Canada Naloxone Market Size and Growth Rate (2015-2025) (USD Million)
Figure 30. Mexico Naloxone Market Size and Growth Rate (2015-2020) (USD Million)
Figure 31. Europe Naloxone Revenue Market Share by Country in 2019
Figure 32. Germany Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 33. United Kingdom Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 34. France Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 35. Russia Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. Italy Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. Asia-Pacific Naloxone Sales Market Share by Region 2018
Figure 38. Asia-Pacific Naloxone Revenue Market Share by Region 2018
Figure 39. China Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Japan Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Korea Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. India Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Southeast Asia Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Australia Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. South America Naloxone Sales Market Share by Country in 2019
Figure 46. South America Naloxone Revenue Market Share by Country in 2019
Figure 47. Brazil Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Argentina Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Saudi Arabia Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Turkey Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Egypt Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. South Africa Naloxone Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Global Revenue Market Share of Naloxone by Type in 2019
Figure 54. Global Revenue Market Share of Naloxone by Application in 2019
Figure 55. Sales Channel: Direct Channel vs Indirect Channel
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets